Form 4 for ELV Elevance Health
Accepted 2025-08-21 00:00:00 ET · period of report 2025-08-19 · accession 0001587697-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-21 | 2025-08-19 | ELV | DeVore Susan D. | Dir | P - Purchase | $312.15 | +1,200 | 3,502 | +52% | +$374.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-19 | P | A | 1,200 | $312.15 | 3,502 | D | — | — | (F1) This transaction was executed in multiple purchases at prices ranging from $312.06 to $312.19. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |